AM-928

N/A

Report date: 2023/10/16 13:34:48

Base Information

Drug NameAM-928
Drug Alias NameAM-928
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-EpCAM
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcadeMab Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcadeMab Biomedical Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A